Royal Bank of Canada »

X4 Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $15k 2.5k 6.02
2025-06-30 $10k 3.1k 3.27

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding X4 Pharmaceuticals

Bain Capital Life Sciences Investors
BVF
Nantahala Capital Management
Rosalind Advisors
Deep Track Capital
Stonepine Capital Management
Kingdon Capital Management
Stempoint Capital
Vanguard Group
Boothbay Fund Management
Pale Fire Capital SE
UBS Group
Susquehanna International
Palumbo Wealth Management
Geode Capital Management

View all funds holding X4 Pharmaceuticals